Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

Journal: PLOS digital health

Publication date: 

Journal: PLOS digital health

Publication Year: 

Authors & Co-authors:  De Brouwer Edward E Becker Thijs T Werthen-Brabants Lorin L Dewulf Pieter P Iliadis Dimitrios D Dekeyser Cathérine C Laureys Guy G Van Wijmeersch Bart B Popescu Veronica V Dhaene Tom T

Early clinical markers of aggressive multiple sclerosis.

Journal: Brain : a journal of neurology

Publication date: 2020

Journal: Brain : a journal of neurology

Publication Year: 2020

Authors & Co-authors:  Malpas Charles B CB Manouchehrinia Ali A Sharmin Sifat S Roos Izanne I Horakova Dana D Havrdova Eva Kubala EK Trojano Maria M Izquierdo Guillermo G Eichau Sara S Bergamaschi Roberto R

Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication date: 

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 

Authors & Co-authors:  Sharmin Sifat S Malpas Charles B CB Roos Izanne I Diouf Ibrahima I Alroughani Raed R Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S Horakova Dana D Havrdova Eva K EK

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication date: 2023

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Roos Izanne I Diouf Ibrahima I Sharmin Sifat S Horakova Dana D Havrdova Eva Kubala EK Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication date: 2023

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Daruwalla Cyrus C Shaygannejad Vahid V Ozakbas Serkan S Havrdova Eva Kubala EK Horakova Dana D Alroughani Raed R Boz Cavit C Patti Francesco F Onofrj Marco M Lugaresi Alessandra A

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication date: 2023

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal: Journal of medical economics

Publication date: 2023

Journal: Journal of medical economics

Publication Year: 2023

Authors & Co-authors:  Spelman T T Herring W L WL Acosta C C Hyde R R Jokubaitis V G VG Pucci E E Lugaresi A A Laureys G G Havrdova E K EK Horakova D D